相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Silent progression in disease activity-free relapsing multiple sclerosis
Bruce A. C. Cree et al.
ANNALS OF NEUROLOGY (2019)
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
Jens Kuhle et al.
NEUROLOGY (2019)
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease
Pratishtha Chatterjee et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions
Colm Elliott et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Prognostic value of serum neurofilaments in patients with clinically isolated syndromes
Gloria Dalla Costa et al.
NEUROLOGY (2019)
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Fredrik Piehl et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Fredrik Piehl et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Christian Barro et al.
BRAIN (2018)
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome
Clara Matute-Blanch et al.
BRAIN (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
CSF-Progranulin and Neurofilament Light Chain Levels in Patients With Radiologically Isolated Syndrome-Sign of Inflammation
Marc Pawlitzki et al.
FRONTIERS IN NEUROLOGY (2018)
CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration
Marc Pawlitzki et al.
FRONTIERS IN NEUROLOGY (2018)
Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis
Tanuja Chitnis et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Neopterin, Inflammation, and Oxidative Stress: What Could We Be Missing?
Steven P. Gieseg et al.
ANTIOXIDANTS (2018)
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
Lenka Novakova et al.
NEUROLOGY (2017)
Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression
Chai K. Lim et al.
SCIENTIFIC REPORTS (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms
Shahin Aeinehband et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response
Manuel Comabella et al.
CURRENT OPINION IN NEUROLOGY (2016)
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
Axel Petzold et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain
Rene Fuertig et al.
BIOANALYSIS (2016)
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
Axel Petzold et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Current evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis
Michael D. Lovelace et al.
FRONTIERS IN IMMUNOLOGY (2016)
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
Josa M. Frischer et al.
ANNALS OF NEUROLOGY (2015)
Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients
Brit Fitzner et al.
AUTOIMMUNITY REVIEWS (2015)
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
J. Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
Jens Kuhle et al.
NEUROLOGY (2015)
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
J. Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Quinolinic Acid Induces Disrupts Cytoskeletal Homeostasis in Striatal Neurons. Protective Role of Astrocyte-Neuron Interaction
Paula Pierozan et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2015)
The phosphorylation status and cytoskeletal remodeling of striatal astrocytes treated with quinolinic acid
Paula Pierozan et al.
EXPERIMENTAL CELL RESEARCH (2014)
Biochemical, histopathological and behavioral alterations caused by intrastriatal administration of quinolic acid to young rats
Paula Pierozan et al.
FEBS JOURNAL (2014)
Kynurenines in the CNS: recent advances and new questions
Laszlo Vecsei et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
The kynurenine pathway in neurodegenerative diseases: Mechanistic and therapeutic considerations
Lin Tan et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Neurofilaments as biomarkers in multiple sclerosis
Charlotte E. Teunissen et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease
Robert Schwarcz et al.
PROGRESS IN NEUROBIOLOGY (2010)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Somatostatin in medium-sized aspiny interneurons of striatum is responsible for their preservation in quinolinic acid and N-Methyl-D-asparate-induced neurotoxicity
Ujendra Kumar
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Mechanisms of inflammation induced tissue injury in multiple sclerosis
Hans Lassmann
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Dendritic and mitochondrial changes during glutamate excitotoxicity
Sam M. Greenwood et al.
NEUROPHARMACOLOGY (2007)
Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis
K. Rejdak et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders
Katalin Sas et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease
MT Sapko et al.
EXPERIMENTAL NEUROLOGY (2006)
Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients
K Rejdak et al.
NEUROSCIENCE LETTERS (2002)
In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum
A Santamaria et al.
NEUROREPORT (2001)
Oligodendrocyte killing by quinolinic acid in vitro
W Cammer
BRAIN RESEARCH (2001)
分享论文
